Objective: Analyze the unreasonable prescriptions of diabetic patients in the outpatient and emergency department of our hospital, and provide references for the rational use of drugs by diabetic patients. Methods: The prescriptions (total 12704) for diabetic patients were collected in Outpatient and Emergency Pharmacy from January to December 2020, and several parameters were counted, such as the basic conditions of diabetic patients, the number, types and proportion of unreasonable prescriptions, and the distribution of different departments. Results: The average age of patients was (63.75±12.02) years old. There were 7692 patients between 60 and 79 years old, accounting for 60.55%, and there were more male patients than female patients; 1,291 unreasonable prescriptions, accounting for 10.16%; The top three in the distribution of irrational prescription departments were 913 in internal medicine of Traditional Chinese Medicine, accounting for 70.72%, 125 in respiratory medicine, accounting for 9.68%, and 98 in neurology, accounting for 7.59%. The prescription failure rates of general internal medicine was the lowest 7.44%, and the prescription failure rate of the dialysis center was the highest 43.75%; Among the unreasonable prescription types, there were 1106 prescriptions with inappropriate drug usage and dosage, accounting for 85.67%, followed by 160 prescriptions with inappropriate dosage form or route of administration, accounting for 12.39%. Conclusion: The prescriptions for diabetic patients in the Outpatient and Emergency Department of our hospital are basically reasonable, but some non-endocrine departments have a high rate of prescription failure. It is necessary to improve the problems of irrational prescriptions to improve the quality of prescriptions and the level of reasonably clinical use of drugs.

Shuhua Shi, Jie Liu, Zhizhong Yuan, Xiaoying Zhou. Analysis and measurements of irrational prescriptions for diabetes' patients in the outpatient and emergency. Frontiers in Medical Science Research (2022) Vol. 4, Issue 10: 41-48. https://doi.org/10.25236/FMSR.2022.041008.

[1] U. Religioni, T. Pakulska, Rational drug use in hospital settings - areas that can be changed, J Med Econ [J]. 2020;23: 1205-1208.

[2] Alberti K ,  Zimmet P ,  Shaw J . Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.[J]. Diabetic Medicine, 2010, 23(5):469-480.

[3] H. Balci Yuce, O. Karatas, F. Tulu, A. Altan, F. Gevrek, Effect of diabetes on collagen metabolism and hypoxia in human gingival tissue: a stereological, histopathological, and immunohistochemical study, Biotech Histochem [J]. 2019; 94: 65-73.

[4]Ministry of Health, Prescription Management Measures, 2007.

[5] Ministry of Health, Notice on "Management Specification for Hospital Prescription Review (Trial)", 2010.

[6] Liang Sen, Han Bing, Fan Lei, et al., Prevalence of diabetes mellitus and associated risk factors in population aged 35-74 years in Henan Province, Chinese Journal of Disease Control [J]. 2018;22: 569-572.

[7] G. Bellelli, A. Bruni, M. Malerba, et al., Geriatric multidimensional assessment for elderly patients with acute respiratory diseases, Eur J Intern Med [J]. 2014;25: 304-311.

[8] Jia Weiping, Guidelines for the Prevention and Treatment of Type 2 Diabetes in China, Diabetes Branch of Chinese Medical Association [J]. 2017;10: 2-67.

[9] Diabetic Nephropathy Multidisciplinary Diagnosis, Treatment and Management Consensus Expert Group, Multidisciplinary Diabetic Nephropathy Diagnosis, Treatment and Management Expert Consensus, General Practice Clinic and Education [J]. 2020;18: 484-487.

[10] Fan Ling, Yu Rong, Wang Yan, Survey on status of non-endocrine medical staffs knowledge about diabetes mellitus, Agricultural Reclamation Medicine [J]. 2013;35: 431-434.

[11] Editorial Department of JDIABETES, Chinese Introduction of Journal of Diabetes 2020 Issue 11, Chinese Journal of Endocrinology and Metabolism [J]. 2020;36: 979-988.

[12] Xu Hui, Investigation and analysis of diabetes drug use in outpatient endocrinology department of our hospital, Northern Pharmacy [J]. 2014;11: 164-165.

[13] Tu Fang, Li Quanzhi, Bian Jing, Zhang Wei, Zhen Jiancun, Analysis of irrational diabetes prescriptions in 22 hospitals in Beijing, Journal of Clinical Drug Therapy [J]. 2018;16: 49-52.

[14] N. Thongtang, N. Tangkittikasem, K. Samaithongcharoen, J. Piyapromdee, V. Srinonprasert, S. Sriussadaporn, Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes, Vasc Health Risk Manag [J]. 2020;16: 367-377.

[15] Wang Xiaochun, Feng Mingli, Tian Jiyun, Cao Qin, A case of megaloblastic anemia caused by metformin combined with atorvastatin, Journal of Clinical Internal Medicine [J]. 2016;33: 711-711.

[16] J. Flory, K. Lipska, Metformin in 2019, JAMA [J]. 2019;321: 1926-1927.

[17] Lin. Jie, Chen Lingdi, Su Yinfa, Analysis of potential inappropriate drug use in 2000 outpatient elderly diabetic patients, Journal of Pharmacy Practice [J]. 2015;33: 474-476.

[18] Zhang Zhaode, Common Adverse Drug Reactions and Rational Drug Use Evaluation in the Elderly, Chinese and Foreign Medicine [J]. 2020;11: 102-104.

[19] Zhu Xiaoyu, Su Lili, Zhao Zhigang, Analysis and improvement measures of irrational drug prescriptions in outpatient pharmacies, Chinese Journal of Clinical Pharmacology [J]. 2020;36: 1887-1912.